189 related articles for article (PubMed ID: 21228368)
1. Concordance of butyrylcholinesterase phenotype with genotype: implications for biochemical reporting.
Parnas ML; Procter M; Schwarz MA; Mao R; Grenache DG
Am J Clin Pathol; 2011 Feb; 135(2):271-6. PubMed ID: 21228368
[TBL] [Abstract][Full Text] [Related]
2. Cholinesterase: phenotyping and genotyping.
Goodall R;
Ann Clin Biochem; 2004 Mar; 41(Pt 2):98-110. PubMed ID: 15025799
[TBL] [Abstract][Full Text] [Related]
3. Two novel mutations in the BCHE gene in patients with prolonged duration of action of mivacurium or succinylcholine during anaesthesia.
Gätke MR; Bundgaard JR; Viby-Mogensen J
Pharmacogenet Genomics; 2007 Nov; 17(11):995-9. PubMed ID: 18075469
[TBL] [Abstract][Full Text] [Related]
4. Identification of human plasma cholinesterase variants in 6,688 individuals using biochemical analysis.
Jensen FS; Skovgaard LT; Viby-Mogensen J
Acta Anaesthesiol Scand; 1995 Feb; 39(2):157-62. PubMed ID: 7793180
[TBL] [Abstract][Full Text] [Related]
5. Determination of butyrylcholinesterase (BChE) phenotypes to predict the risk of prolonged apnea in persons receiving succinylcholine in the healthy population of western Iran.
Vaisi-Raygani A; Rahimi Z; Kharazi H; Tavilani H; Aminiani M; Kiani A; Vaisi-Raygani A; Pourmotabbed T
Clin Biochem; 2007 Jun; 40(9-10):629-33. PubMed ID: 17350607
[TBL] [Abstract][Full Text] [Related]
6. Human butyrylcholinesterase L330I mutation belongs to a fluoride-resistant gene, by expression in human fetal kidney cells.
Sudo K; Maekawa M; Akizuki S; Magara T; Ogasawara H; Tanaka T
Biochem Biophys Res Commun; 1997 Nov; 240(2):372-5. PubMed ID: 9388484
[TBL] [Abstract][Full Text] [Related]
7. "Warning card" as a prevention of prolonged apnea in children.
Lajtman Z; Surina B; Bartolek D; Car D; Gasparović S; Kirincić N; Rudez J
Coll Antropol; 2002 Dec; 26 Suppl():129-37. PubMed ID: 12674844
[TBL] [Abstract][Full Text] [Related]
8. Activity and polymorphisms of butyrylcholinesterase in a Polish population.
Jasiecki J; Jońca J; Żuk M; Szczoczarz A; Janaszak-Jasiecka A; Lewandowski K; Waleron K; Wasąg B
Chem Biol Interact; 2016 Nov; 259(Pt B):70-77. PubMed ID: 27109752
[TBL] [Abstract][Full Text] [Related]
9. Frequency of butyrylcholinesterase gene mutations in individuals with abnormal inhibition numbers: an Italian-population study.
Lando G; Mosca A; Bonora R; Azzario F; Penco S; Marocchi A; Panteghini M; Patrosso MC
Pharmacogenetics; 2003 May; 13(5):265-70. PubMed ID: 12724618
[TBL] [Abstract][Full Text] [Related]
10. Butyrylcholinesterase genes in individuals with abnormal inhibition numbers and with trace activity: one common mutation and two novel silent genes.
Dey DC; Maekawa M; Sudo K; Kanno T
Ann Clin Biochem; 1998 Mar; 35 ( Pt 2)():302-10. PubMed ID: 9547905
[TBL] [Abstract][Full Text] [Related]
11. Butyrylcholinesterase (BCHE) genotyping for post-succinylcholine apnea in an Australian population.
Yen T; Nightingale BN; Burns JC; Sullivan DR; Stewart PM
Clin Chem; 2003 Aug; 49(8):1297-308. PubMed ID: 12881446
[TBL] [Abstract][Full Text] [Related]
12. Association of variants of the -116 site of the butyrylcholinesterase BCHE gene to enzyme activity and body mass index.
Furtado-Alle L; Andrade FA; Nunes K; Mikami LR; Souza RL; Chautard-Freire-Maia EA
Chem Biol Interact; 2008 Sep; 175(1-3):115-8. PubMed ID: 18550040
[TBL] [Abstract][Full Text] [Related]
13. Timing of blood sampling for butyrylcholinesterase phenotyping in patients with prolonged neuromuscular block after mivacurium or suxamethonium.
Mintjens N; Brummans R; Soetens F; Claes KBM; Vanlinthout LE
Acta Anaesthesiol Scand; 2021 Feb; 65(2):182-187. PubMed ID: 33010031
[TBL] [Abstract][Full Text] [Related]
14. Response to succinylcholine in patients carrying the K-variant of the butyrylcholinesterase gene.
Bretlau C; Sørensen MK; Vedersoe AL; Rasmussen LS; Gätke MR
Anesth Analg; 2013 Mar; 116(3):596-601. PubMed ID: 23400986
[TBL] [Abstract][Full Text] [Related]
15. Expression of three naturally occurring genetic variants (G75R, E90D, I99M) of the BCHE gene of human butyrylcholinesterase.
Mikami LR; Wieseler S; Souza RL; Schopfer LM; Lockridge O; Chautard-Freire-Maia EA
Pharmacogenet Genomics; 2007 Sep; 17(9):681-5. PubMed ID: 17700357
[TBL] [Abstract][Full Text] [Related]
16. Butyrylcholinesterase gene mutations in patients with prolonged apnea after succinylcholine for electroconvulsive therapy.
Mollerup HM; Gätke MR
Acta Anaesthesiol Scand; 2011 Jan; 55(1):82-6. PubMed ID: 21029050
[TBL] [Abstract][Full Text] [Related]
17. [Danish Cholinesterase Research Unit diagnoses patients with prolonged paralysis after succinylcholine and mivacurium].
Eskildsen KZ; Gätke MR
Ugeskr Laeger; 2015 Apr; 177(18):866-8. PubMed ID: 26539575
[TBL] [Abstract][Full Text] [Related]
18. [Danish Cholinesterase Research Unit diagnoses patients with prolonged paralysis after succinylcholine and mivacurium].
Eskildsen KZ; Gätke MR
Ugeskr Laeger; 2014 Mar; 176(12A):. PubMed ID: 25350885
[TBL] [Abstract][Full Text] [Related]
19. Patients with prolonged effect of succinylcholine or mivacurium had novel mutations in the butyrylcholinesterase gene.
Wichmann S; Færk G; Bundgaard JR; Gätke MR
Pharmacogenet Genomics; 2016 Jul; 26(7):351-6. PubMed ID: 27031121
[TBL] [Abstract][Full Text] [Related]
20. Possible influence of BCHE locus of butyrylcholinesterase on stature and body mass index.
Souza RL; Fadel-Picheth C; Allebrandt KV; Furtado L; Chautard-Freire-Maia EA
Am J Phys Anthropol; 2005 Mar; 126(3):329-34. PubMed ID: 15386241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]